Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,012,208
-
Share change
-
+718,907
-
Total reported value
-
$24,921,000
-
Price per share
-
$4.15
-
Number of holders
-
25
-
Value change
-
+$1,571,662
-
Number of buys
-
16
-
Number of sells
-
13
Institutional Holders of CATABASIS PHARMACEUTICALS IN - COM NEW as of Q1 2020
As of 31 Mar 2020,
CATABASIS PHARMACEUTICALS IN - COM NEW was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,012,208 shares.
The largest 10 holders included
FEDERATED HERMES, INC., VANGUARD GROUP INC, Samsara BioCapital, LLC, SV Health Investors, LLC, DIMENSIONAL FUND ADVISORS LP, BlackRock Inc., Blackstone Group Inc, Worth Venture Partners, LLC, Parkman Healthcare Partners LLC, and OPPENHEIMER & CO INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.